Prolonged continuous i.v. "desensitization" in Tienam hypersensitivity.
Confino-Cohen
R
R
Allergy/Clinical Immunology Unit, Sapir Medical Center, Melr General Hospital, Kfar Saba, Israel.
Goldberg
A
A
Lang
R
R
D015377:Cilastatin / Q000008:administration & dosage / Q000009:adverse effects; D000077728:Cilastatin, Imipenem Drug Combination; D003888:Desensitization, Immunologic / Q000379:methods*; D004338:Drug Combinations; D004342:Drug Hypersensitivity / Q000188:drug therapy*; D004359:Drug Therapy, Combination / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage / Q000009:adverse effects; D007262:Infusions, Intravenous; D007710:Klebsiella Infections / Q000188:drug therapy; D008875:Middle Aged
D004338:Drug Combinations; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination